EXIT (ex utero intrapartum treatment) in a growth restricted fetus with tracheal atresia

S Kyle Gonzales; Steven Goudy; Kara Prickett; Jane Ellis

doi:10.1016/j.ijporl.2017.12.010

EXIT (ex utero intrapartum treatment) in a growth restricted fetus with tracheal atresia

Int J Pediatr Otorhinolaryngol. 2018 Feb:105:72-74. doi: 10.1016/j.ijporl.2017.12.010. Epub 2017 Dec 9.

Authors

S Kyle Gonzales¹, Steven Goudy², Kara Prickett², Jane Ellis³

Affiliations

¹ Division of Maternal Fetal Medicine, Emory University, Atlanta, GA, USA. Electronic address: kyle.gonzales@emory.edu.
² Division of Otolaryngology, Head & Neck Surgery, Emory University, Atlanta, GA, USA.
³ Division of Maternal Fetal Medicine, Emory University, Atlanta, GA, USA.

PMID: 29447823
DOI: 10.1016/j.ijporl.2017.12.010

Abstract

Congenital high airway obstruction syndrome (CHAOS) encompasses a heterogeneous group of pathologies leading to poor lung development and difficulty oxygenating the newborn after delivery. While previously uniformly fatal, the ex utero intrapartum therapy (EXIT) procedure has provided a method to treat these patients and provide an airway to potentiate survival. We present a patient diagnosed prenatally with CHAOS secondary to tracheal atresia complicated by severe intra-uterine growth restriction (IUGR) who was successfully delivered via an EXIT procedure at 33-weeks. Multidisciplinary care and planning is paramount.

Publication types

Case Reports

MeSH terms

Airway Obstruction / etiology
Constriction, Pathologic / complications
Constriction, Pathologic / surgery*
Delivery, Obstetric / methods*
Female
Fetal Diseases
Fetal Growth Retardation / etiology*
Fetus
Humans
Infant, Newborn
Magnetic Resonance Imaging
Plastic Surgery Procedures / methods*
Pregnancy
Trachea / abnormalities*
Trachea / surgery
Young Adult

Supplementary concepts

Tracheal agenesis